ARCT
Companies
NASDAQ
Arcturus Therapeutics Holdings Inc.
Health Care
$12.35
-$4.62 (-27.22%)
Price Chart
Overview
About ARCT
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.
Market Cap
$857.0M
Volume
5.5M
Avg. Volume
5.3M
P/E Ratio
-3.9215245
Dividend Yield
0.00%
Employees
182.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.26
High Correlation
Volatility
High (0.74)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ARCT shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025